ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Watson Sells Stake In Taiwan’s ScinoPharm

by Jean-François Tremblay
March 8, 2010 | APPEARED IN VOLUME 88, ISSUE 10

Watson Pharmaceuticals will sell its 31% stake in Taiwan’s ScinoPharm, a custom producer of active pharmaceutical ingredients, to Uni-President. A major food manufacturer in Taiwan and China, Uni-President already owns a substantial portion of ScinoPharm. The firm’s other major shareholders are Taiwan Sugar and the Taiwanese government. Watson started acquiring a stake in ScinoPharm in 2004 but says its priorities have changed now that it has increased its own manufacturing capability. In 2006, Watson acquired the Indian pharmaceutical ingredients maker Sekhsaria Chemicals.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment